HIGHLIGHTS
SUMMARY
The trial itself is based on the premise that context matters: the question of whether high flow oxygen is superior to standard flow has been explored in multiple HIC settings, but different epidemiology and resources may change the answer as to whether high flow oxygen should be used in LMIC settings for the best patient- and systems-level outcomes. To identify the optimal SpO2 range for patients enrolled in the trial, the authors conducted a scoping literature review regarding SpO2 targets for patients with hypoxemia. Henry et_al found that, compared to white patients, Black . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.